Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Paul Morten Mau-Sørensen

Morten Mau-Sorensen


The Phase Unit, Dept. Of Oncology
University Hospital

Morten Mau-Sørensen holds a position as chief physician at the Phase I unit, Department of Oncology, Rigshospitalet, Copenhagen, Denmark. He is president of the Danish Association for Cancer Research and a member of the Danish Health Medical Agengcy’s panel on experimental therapy. Dr. Mau-Sørensen’s research focuses on early clinical development of cancer therapies including first-in-man trials, biomarkers, targeted therapies based on genomic profiling and circulating tumor DNA. 

Dr  Mau-Sørensen is member of the ESMO Faculty on Principles of Clinical Trials and Systemic Therapy

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.